Developing new antimicrobial drugs is financially unappealing for pharmaceutical corporations, Sally Davies has said
Antimicrobial resistance could claim 40 million lives by 2050 if left unchecked, UK Special Envoy on AMR and England’s former chief medical officer, Sally Davies, told the Observer on Sunday.
Antimicrobial resistance (AMR) occurs when bacteria, viruses and other types of germs become stronger than the medications used to treat them – creating so-called “superbugs.
Заголовки